FDA Inspection 879027 — Aspire Pharmaceuticals, Inc.
The FDA completed an inspection of Aspire Pharmaceuticals, Inc. on May 19, 2014 in Somerset, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 19, 2014
- Fiscal Year
- 2014
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Somerset, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15761 | 21 CFR 111.205(b)(1) | Master manufacturing record - specifications; quality |